I've held LBT since mid 2016 when there was a flurry of activity then nothing. Lately I have been accumulating since about May 2021. At the moment it has been paying off but I would like some feedback from others who may know about the area of AI and automating cell culture examination as to what problems LBT may have in breaking into the market.
EG
Does anyone know who the big players are who currently do the same thing if any? LBT suggest that they are the only one who use AI in their machines?
I have read of a company BD Kiestra who seems to be doing similar things and is already in the market. Would this be correct?
And advice would be gratefully accepted Thanks
LBT Quo Vadis
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.45M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $1.627K | 85.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1409999 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 264381 | 3 |
View Market Depth
| Last trade - 15.00pm 06/05/2024 (20 minute delay) ? |
| LBT (ASX) Chart |